The 2017 Preventive and Therapeutic Vaccine Market forecast report focuses on
regional growth for 15+ countries, leading industry companies, applications of Preventive
and Therapeutic Vaccine and more with an aim to help take business decisions.
Global Preventive and Therapeutic
Vaccine Market size is poised to experience high growth, primarily because of
its fast-growing nature and expanding market size. Vaccine developments have
been considerably increasing since recent past and their adoption is also
rising in various regions across the globe. Practices by the major companies,
such as consistent research and innovation and development for introducing
recent technologies to curb expense and reduce time will spur vaccine market
worldwide.
Increasing government funding for
vaccine development, rising R&D investments, the introduction of faster
vaccine development technologies, and improvements in vaccine design are some
of the factors, which will fuel market growth over the coming years. However,
the high cost of vaccine storage and transportation and stringent regulations
for the approval of vaccines will hamper the market expansion.
Request for an in-depth table
of contents for this report @ https://www.gminsights.com/request-toc/upcoming/1645
Global preventive and
therapeutic vaccine market is broadly classified into preventive vaccine market
and therapeutic vaccine market. Based on the product type, preventive vaccine
market is segmented into pediatric and adult vaccines and therapeutic vaccine
is segmented into neurological disease vaccines, autoimmune disease vaccines,
infectious disease vaccines, and cancer vaccines.
Soaring prevalence of diseases
among children is resulting in the implementation of awareness programs by
governments across the globe. Moreover, significant advancements in
vaccinology, such as the emergence, development, and usage of hepatitis B
vaccine, should augment the business growth over the coming years.
Strategies adopted by major
vendors in the market, such as the development of improved influenza vaccine
that broaden vaccine-induced immunity, enhancing the vaccine immunogenicity,
and introducing alternative delivery will result in greater adoption of
influenza vaccine in future.
A significant factor
proliferating the demand for certain vaccines is high effectiveness; for
example, the experimental shingles vaccine protects about 90% of adults, the
present Zostovax vaccine reduces the risk of shingles by about half and
immunity wanes within five years. In coming years, more vaccines will have
better effectiveness and therefore, these vaccines will experience high
adoption rates.
Browse key industry insights from the report Preventive
and Therapeutic Vaccine Market in detail along with the table of contents:
Based on the technology type, the vaccine market is
segmented into live attenuated, toxoid, conjugate, inactivated & subunit,
and recombinant. The conjugate vaccines hold the largest market share; the
growth of this segment is associated with the massive government support for
vaccine development and rising investments in R&D.
The U.S. preventive and therapeutic vaccine market enjoys
the major share because of the presence of advanced and active R&D
establishment. It dominates the therapeutic vaccine market, which is driven by
large pharmaceutical industry base, best-in-class healthcare infrastructure,
and high spending on healthcare by the citizens. The government support for
research and development of vaccines, investments for vaccine research, and
ubiquity of different diseases fuel the growth of this region.
Europe preventive and therapeutic vaccine market is the
second largest market after North America. Research, innovation, and
development conducted by MNCs in the field of vaccine production by utilizing
their deep expertise are advantages for this region. Increasing prevalence of
diseases in children and adults will generate demand for more preventive
vaccine in coming years; to cater to this demand, big companies, such as
Pfizer, Merck, Sanofi, and GlaxoSmithKline, will play a key role in the future.
In the APAC
preventive and therapeutic vaccine market, the growing incidences of cancer
& HIV cases will give rise to the demand for vaccine and therefore boost
the market growth. Improving healthcare sector, increasing healthcare
expenditure, and government initiatives will render a high impact on adoption
rates of vaccines. WHO estimates a huge potential for the market with the
arrival of new improved preventive and therapeutic vaccines. China and India
are expected to witness a boom in demand and are expected to attain maximum
growth over the next 10 years, owing to the escalating prevalence of various
infectious diseases and improving economic indicators.
Latin
America therapeutic vaccines targeting cancers and allergies offer vast
opportunities for fresh players entering this regional market. First
FDA-approved therapeutic vaccine, Provenge by Dendreon, treating prostate
cancer acknowledged the potential of vaccines in therapeutics. In the coming
years, it is expected that the industry will experience improvements in vaccine
delivery methodologies, vaccine design, manufacturing in a large-scale process,
and development of personalized vaccines. Therapeutic vaccines address the
demand for safe and cost-effective drugs for the treatment of cancer and HIV,
fueling the market growth.
Saudi Arabia
and South Africa dominates the Middle East & Africa preventive and
therapeutic vaccine market. R&D funding for diseases, such as HIV and
cancer, by the government offers a novel opportunity for the vaccine market.
Wide usage of vaccines includes, inactivated, live attenuated, toxoid, subunit,
conjugate, dendritic cell, and synthetic. Preventive vaccine is the leading
type due to high awareness among people.
Prominent
players in the global preventive and therapeutic vaccine market are Sanofi
Pasteur, Merck & Co., Pfizer, and Bristol-Myers Squibb. The largest players
account for 80% of the global revenue. AstraZeneca, Johnson & Johnson, and
Abbott are the other notable industry players.
Browse
Related Reports:
Precision Medicine Market Size
By Technology (Big
Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion
Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry
Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France,
Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South
Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends,
Competitive Market Share & Forecast, 2016 – 2023
About Global
Market Insights:
Global Market Insights,
Inc., headquartered in Delaware, U.S., is a global market research and
consulting service provider; offering syndicated and custom research reports
along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market
data specially designed and presented to aid strategic decision making. These exhaustive
reports are designed via a proprietary research methodology and are available
for key industries such as chemicals, advanced materials, technology, renewable
energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment